HealthEconomics.Com

Connected. Community.

  • facebook
  • linkedin
  • twitter
  • vimeo
  • rss
  • News
  • Jobs
    • HE Jobs Portal
    • View all Jobs
    • Post a Job
  • Value, Evidence and Access Marketplace
    • Visite the Marketplace
    • On-demand Webinar
  • Industry Events
    • HealthEconomics.Com Webinars
    • View Conferences
    • View Webinars
    • Archived Webinars
  • Newsletters
    • Subscribe
    • View All
  • Blog
  • Resources
    • Value Communication
    • Free Marketing Consultation!
    • The Future of Print Medical Journals: How to Stay Relevant
    • Be a Better Writer
    • White Papers
    • Education Resources
    • Syndicated Reports
    • Books
    • Databases
    • Blogs
      • HE-Artists
      • Podcasts
  • HE Institute
You are here: Home / Featured / Government, Big Pharma, and The People: A Century of Dis-Ease

Government, Big Pharma, and The People: A Century of Dis-Ease

It can be said that society shapes our values toward drugs and drugs shape society. And while drug prices are at the forefront of many voters’ minds, they are not actually the main reason the U.S. spends so much on health care. Even though pharmaceuticals account for a relatively small share of total US healthcare expenditure, the pharmaceutical industry occupies center stage in the debate on reigning in healthcare costs. Because of this, the industry has had, for many years, an outsized claim to fame and controversy, praise and criticisms, and has remained a convenient scapegoat for everything from perpetuating the so-called “sick care” industry to mounting and financing organized opposition to medical marijuana. However, the industry’s true role in the overall health care system is far more complex than most are aware of.

In his latest book ‘Government, Big Pharma, and The People: A Century of Dis-Ease’, Dr. Mickey C. Smith draws upon his 50 years in Big Pharma and academia to fully characterize what is often thought of as the danse macabre between Big Pharma, government, providers, payers, and patients, leaving readers with a complete understanding of the dynamics of the industry and the controversies surrounding it. Smith concludes his well-researched and compelling work with an inside look at how regulations, marketing, and the press affect Big Pharma’s business for better or for worse. Find out more here.



You might also be interested in:

  • Trump's "Buy American" Executive Order Could Raise Drug Prices 08/06/2020
  • Robert Dubois, MD, PhD, Steps in as Interim President and CEO… 09/01/2020
  • Key Innovations Coming From The Next Generation of PBM’s 08/12/2020
  • Scientist.com Reveals Expanded HEOR, Value, and RWE Category,… 03/23/2021
  • Scientist.com to Acquire HealthEconomics.Com, the World’s… 12/15/2020
  • New Roadmap Aims to Transform Healthcare Landscape by… 08/13/2020
  • [Book Release] Value-Based Drug Pricing Guide on Flawed $500… 03/10/2021

 

View All JobsPost a JobView Current NewsletterSubscribe to Newsletters

Syndicated Reports

Artificial Intelligence in Healthcare Market Forecast to 2027 – COVID-19 Impact and Global Analysis by Component, Application, End User, and Geography

Healthcare Trends & Forecasts in 2021: Performance Expectations for the Healthcare Industry

Medical Affairs Outsourcing Market 2021 Overview, Trends, Size, Growth and 2028 Future Insights

Bioinformatics Market Research Report by Product, by End User – Global Forecast to 2025 – Cumulative Impact of COVID-19

White Papers

What to Look for in an Informatics Platform for Life Sciences R&D

Beyond The Field: Evolving Field Medical Engagement And Talent For The Future

Innovating the Delivery of Patient Support: Branded Patient Support programs for Today’s Health Consumer

Healthcare Cost Containment: Best Practices & Recommendations

HealthEconomics.Com

HealthEconomics.Com

  • News
  • Conferences
  • Reports
  • Jobs
  • Consulting
  • Newsletters
  • White Papers

More Links

  • Jobs
  • Education
  • Graduate Schools
  • Webinar Services

Support & Contact

  • Contact Us

About

  • About Us
  • Advertise
  • Webinar Services
  • HE Institute
  • Testimonials
  • Privacy Policy

Stay Connected

  • facebook
  • twitter
  • linkedin
  • pinterest
  • google-plus
  • youtube
  • rss

HealthEconomics.Com is the world’s most comprehensive and credible CONNECTED COMMUNITYTM that serves as the global link to the health economics & outcomes research (HEOR) and pharma market access stakeholder communities.

HEALTHECONOMICS HZ SMALL V2

HealthEconomics.Com is the world’s most comprehensive and credible CONNECTED COMMUNITYTM that serves as the global link to the health economics & outcomes research (HEOR) and pharma market access stakeholder communities, proving news, education, jobs, resources, policy updates, consulting, advertising, all available via website, newsletters, and social media.

© 2017 Health Economics. All rights reserved.

  • News
  • Jobs
    • HE Jobs Portal
    • View all Jobs
    • Post a Job
  • Value, Evidence and Access Marketplace
    • Visite the Marketplace
    • On-demand Webinar
  • Industry Events
    • HealthEconomics.Com Webinars
    • View Conferences
    • View Webinars
    • Archived Webinars
  • Newsletters
    • Subscribe
    • View All
  • Blog
  • Resources
    • Value Communication
    • Free Marketing Consultation!
    • The Future of Print Medical Journals: How to Stay Relevant
    • Be a Better Writer
    • White Papers
    • Education Resources
    • Syndicated Reports
    • Books
    • Databases
    • Blogs
      • HE-Artists
      • Podcasts
  • HE Institute